title: Differences in butadiene adduct formation between rats and mice not due to selective inhibition of CYP2E1 by butadiene metabolites.
abstract: CYP2E1 metabolizes 1,3-butadiene (BD) into genotoxic and possibly carcinogenic 1,2-epoxy-3-butene (EB), 1,2:3,4-diepoxybutane (DEB), and 1,2-epoxy-3,4-butanediol (EB-diol). The dose response of DNA and protein adducts derived from BD metabolites increases linearly at low BD exposures and then saturates at higher exposures in rats, but not mice. It was hypothesized that differences in adduct formation between rodents reflect more efficient BD oxidation in mice than rats. Herein, we assessed whether BD-derived metabolites selectively inhibit rat but not mouse CYP2E1 activity using B6C3F1 mouse and Fisher 344 rat liver microsomes. Basal CYP2E1 activities toward 4-nitrophenol were similar between rodents. Through IC50 studies, EB was the strongest inhibitor (IC50 54μM, mouse; 98μM, rat), BD-diol considerably weaker (IC50 1200μM, mouse; 1000μM, rat), and DEB inhibition nonexistent (IC50>25mM). Kinetic studies showed that in both species EB and BD-diol inhibited 4-nitrophenol oxidation through two-site mechanisms in which inhibition constants reflected trends observed in IC50 studies. None of the reactive epoxide metabolites inactivated CYP2E1 irreversibly. Thus, there was no selective inhibition or inactivation of rat CYP2E1 by BD metabolites relative to mouse Cyp2e1, and it can be inferred that CYP2E1 activity toward BD between rodent species would similarly not be impacted by the presence of BD metabolites. Inhibition of CYP2E1 by BD metabolites is then not responsible for the reported species difference in BD metabolism, formation of BD-derived DNA and protein adducts, mutagenicity and tumorigenesis.
authors.affiliation: Department of Chemistry and Biochemistry, University of Arkansas at Fayetteville, Fayetteville, AR 72701, USA.
authors.forename: Kaila M
authors.initials: KM
authors.lastname: Pianalto
authors.forename: Jessica H
authors.initials: JH
authors.lastname: Hartman
authors.forename: Gunnar
authors.initials: G
authors.lastname: Boysen
authors.forename: Grover P
authors.initials: GP
authors.lastname: Miller
mesh_terms: D000818:Animals; D002070:Butadienes / Q000633:toxicity*; D002273:Carcinogens / Q000633:toxicity*; D019392:Cytochrome P-450 CYP2E1 / Q000235:genetics* / Q000378:metabolism; D065691:Cytochrome P-450 CYP2E1 Inhibitors; D020128:Inhibitory Concentration 50; D008099:Liver / Q000187:drug effects; D051379:Mice; D008815:Mice, Inbred Strains; D008862:Microsomes, Liver / Q000187:drug effects / Q000378:metabolism; D009596:Nitrophenols / Q000037:antagonists & inhibitors / Q000378:metabolism; D051381:Rats; D011916:Rats, Inbred F344; D013045:Species Specificity
chemical_list: D002070:Butadienes; D002273:Carcinogens; D065691:Cytochrome P-450 CYP2E1 Inhibitors; D009596:Nitrophenols; D019392:Cytochrome P-450 CYP2E1; C031763:1,3-butadiene; C024836:4-nitrophenol
keywords: 1,2-epoxy-3,4-butanediol; 1,2-epoxy-3-butene; 1,3-butadiene; 3-butene-1,2-diol; BD; BD-diol; Butadiene; CYP2E1; Cooperativity; EB; EB-diol; HPLC; Inactivation; LM; Mouse; Rat; high-performance liquid chromatography; liver microsomes
references.citation: Chem Biol Interact. 2007 Mar 20;166(1-3):207-18
references.pmid: 16854403
references.citation: Toxicol Sci. 2010 Jun;115(2):322-9
references.pmid: 20176624
references.citation: Tob Control. 2003 Dec;12(4):424-30
references.pmid: 14660781
references.citation: Cancer Res. 2008 Oct 1;68(19):8014-21
references.pmid: 18829559
references.citation: Chem Biol Interact. 2007 Mar 20;166(1-3):170-5
references.pmid: 17298833
references.citation: Xenobiotica. 2013 Sep;43(9):755-64
references.pmid: 23327532
references.citation: Mol Pharmacol. 1986 Apr;29(4):399-404
references.pmid: 3702859
references.citation: Chem Biol Interact. 2007 Mar 20;166(1-3):93-103
references.pmid: 16616907
references.citation: Carcinogenesis. 1992 Jul;13(7):1143-53
references.pmid: 1638680
references.citation: Chem Res Toxicol. 2008 Jan;21(1):189-205
references.pmid: 18052110
references.citation: Anal Biochem. 1996 Jun 1;237(2):260-73
references.pmid: 8660575
references.citation: Chem Res Toxicol. 2007 May;20(5):839-47
references.pmid: 17455958
references.citation: Carcinogenesis. 1994 Aug;15(8):1479-86
references.pmid: 8055623
references.citation: Chem Res Toxicol. 2001 Dec;14(12):1590-5
references.pmid: 11743741
references.citation: Chem Biol Interact. 2011 Jun 30;192(1-2):150-4
references.pmid: 20974116
references.citation: Arch Biochem Biophys. 1995 Feb 20;317(1):299-304
references.pmid: 7872797
references.citation: Toxicol Sci. 2012 Jan;125(1):30-40
references.pmid: 22003190
references.citation: Arch Biochem Biophys. 1994 Jun;311(2):342-9
references.pmid: 8203896
references.citation: Chem Res Toxicol. 2002 Dec;15(12):1561-71
references.pmid: 12482238
references.citation: Rep Carcinog. 2011;12:
references.pmid: 21822324
references.citation: Crit Rev Toxicol. 1997 Jan;27(1):1-108
references.pmid: 9115622
references.citation: IARC Monogr Eval Carcinog Risks Hum. 2008;97:3-471
references.pmid: 20232717
references.citation: Carcinogenesis. 1992 Sep;13(9):1633-8
references.pmid: 1394848
references.citation: Toxicol Lett. 2011 Dec 15;207(3):286-90
references.pmid: 21983653
references.citation: Toxicology. 1997 Nov 21;123(1-2):125-34
references.pmid: 9347927
references.citation: Chem Res Toxicol. 1995 Mar;8(2):182-7
references.pmid: 7766800
references.citation: Arch Toxicol. 1986 Apr;58(4):235-8
references.pmid: 3718226
references.citation: Chem Res Toxicol. 2012 Mar 19;25(3):706-12
references.pmid: 22181695
references.citation: J Biol Chem. 2008 Feb 8;283(6):3487-3496
references.pmid: 18056994
references.citation: Carcinogenesis. 1995 Oct;16(10):2287-93
references.pmid: 7586124
references.citation: Mutat Res. 2009 Aug;678(2):76-94
references.pmid: 19465146
references.citation: Chem Res Toxicol. 2009 Jun;22(6):1069-76
references.pmid: 19364102
references.citation: J Pharmacol Exp Ther. 2004 Jul;310(1):281-90
references.pmid: 14988423
references.citation: Biol Chem. 2002 Oct;383(10):1553-64
references.pmid: 12452431
references.citation: Natl Toxicol Program Tech Rep Ser. 1984 Aug;288:1-111
references.pmid: 12748715